Can extra support make telemedicine work better for diabetes?

NCT ID NCT06740435

Ongoing Knowledge-focused Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether an enhanced telemedicine program is practical for adults with complex type 2 diabetes who use insulin and have other health conditions. Fifty participants will receive either standard telemedicine care or an enhanced version with extra pre-visit prep, in-visit support, and post-visit follow-up. The main goal is to see if the enhanced program is feasible and acceptable, not to prove it improves health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Enhanced telemedicine program with pre-visit prep, in-visit support, and post-visit follow-up
What this could lead to: If successful, this could show that a more supportive telemedicine approach is practical and may improve care for people with complex diabetes.
What could go wrong: This is a small pilot study with only 50 participants, so results may not apply to everyone. It focuses on feasibility, not on proving health improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.